Challenges and Enablers of Deprescribing: A General Practitioner Perspective
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
AIMS: Deprescribing is the process of reducing or discontinuing medicines that are unnecessary or deemed to be harmful. We aimed to investigate general practitioner (GP) perceived challenges to deprescribing in residential care and the possible enablers that support GPs to implement deprescribing. METHODS: A qualitative study was undertaken using semi-structured, face-to-face interviews from two cities in New Zealand and a purpose-developed pilot-tested interview schedule. Interviews were recorded with permission and transcribed verbatim. Transcripts were read and re-read and themes were identified with iterative building of a coding list until all data was accounted for. Interviews continued until saturation of ideas occurred. Analysis was carried out with the assistance of a Theoretical Domains Framework (TDF) and constant comparison techniques. Several themes were identified. Challenges and enablers of deprescribing were determined based on participants' answers. RESULTS: Ten GPs agreed to participate. Four themes were identified to define the issues around prescribing for older people, from the GPs' perspectives. Theme 1, the 'recognition of the problem', discusses the difficulties involved with prescribing for older people. Theme 2 outlines the identified behaviour change factors relevant to the problem. Deprescribing challenges were drawn from these factors and summarised in Theme 3 under three major headings; 'prescribing factors', 'social influences' and 'policy and processes'. Deprescribing enablers, based on the opinions and professional experience of GPs, were retrieved and summarised in Theme 4. CONCLUSION: The process of deprescribing is laced with many challenges for GPs. The uncertainty of research evidence in older people and social factors such as specialists' and nurses' influences were among the major challenges identified. Deprescribing enablers encompassed support for GPs' awareness and knowledge, improvement of communication between multiple prescribers, adequate reimbursement and pharmacists being involved in the multidisciplinary team.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Cited by 13,126
But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation
Lincoln, Y. S., & Guba, E. G. (1986) · New Directions for Program Evaluation · doi:10.1002/ev.1427 · Cited by 3,668
Making psychological theory useful for implementing evidence based practice: a consensus approach
Michie, S. (2005) · Quality and Safety in Health Care · doi:10.1136/qshc.2004.011155 · Cited by 3,440 · cited 7×
“Analysis was carried out with the assistance of a Theoretical Domains Framework (TDF) and constant comparison tech- niques.”
BackgroundMethodInfluentialBoyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581 · cited 2×
“The prevalence of single-disease guidelines for initiating treatments is a significant driver to polypharmacy and is a hindrance to deprescribing [10].”
BackgroundGnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176 · cited 1×
“Deprescribing describes the process of reducing or discontinuing medicines that are un-necessary or deemed harmful [1, 2].”
BackgroundPotential Pitfalls of Disease-Specific Guidelines for Patients with Multiple Conditions
Tinetti, M. E., Bogardus, S. T., & Agostini, J. V. (2004) · New England Journal of Medicine · doi:10.1056/nejmsb042458 · Cited by 927 · cited 1×
“Paradoxically, there is growing evidence that older people with multiple conditions have poorer outcomes when treated according to disease-specific guidelines compared to other patients [10, 21].”
BackgroundAnderson, K., Stowasser, D., Freeman, C., & Scott, I. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006544 · Cited by 725 · cited 1×
“In this case the responsibility for stopping inappropriate medicines is devolved to the new prescriber, but not the necessary information required for decision making [27].”
BackgroundCampbell, A. J., Robertson, M. C., Gardner, M. M., Norton, R. N., & Buchner, D. M. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb03843.x · Cited by 552 · cited 1×
“Deprescribing is a proposed antidote to the harms of polypharmacy and is associated with numerous health benefits including improvement in cognition [3], a reduction in falls [4], a decrease in fractures [5], better medication adherence [6] and improvement in quality of life [3].”
BackgroundGarfinkel, D., & Mangin, D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.355 · Cited by 533 · cited 1×
“Deprescribing is a proposed antidote to the harms of polypharmacy and is associated with numerous health benefits including improvement in cognition [3], a reduction in falls [4], a decrease in fractures [5], better medication adherence [6] and improvement in quality of life [3].”
BackgroundSelf-citationSchoen, C., Osborn, R., Squires, D., Doty, M., Pierson, R., & Applebaum, S. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0923 · Cited by 446 · cited 1×
“shown that those patients who visit four or more physicians experience problems such as conflicting medical advice, lack of access to laboratory test results and more commonly, duplication of laboratory tests from multiple prescribers [26].”
Background
Cited by
Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews
Davies, L. E., Spiers, G., Kingston, A., Todd, A., Adamson, J., & Hanratty, B. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.10.022 · Cited by 544
Reeve, E., Thompson, W., & Farrell, B. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.12.021 · Cited by 331
Metadata
- Authors
- Ailabouni, N. J., Nishtala, P. S., Mangin, D., & Tordoff, J. M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-19
- Volume
- 11
- Issue
- 4
- Pages
- e0151066
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2340507627
- Cited by
- 209
- References
- 29
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.